These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16326085

  • 1. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of drying on extruded pellets based on kappa-carrageenan.
    Thommes M, Blaschek W, Kleinebudde P.
    Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
    [Abstract] [Full Text] [Related]

  • 4. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
    Dukić-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C.
    Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
    [Abstract] [Full Text] [Related]

  • 7. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 8. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.
    Bornhöft M, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2005 Jan; 59(1):127-31. PubMed ID: 15567309
    [Abstract] [Full Text] [Related]

  • 9. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 16; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 15. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M, Kleinebudde P.
    AAPS PharmSciTech; 2007 Nov 09; 8(4):E95. PubMed ID: 18181555
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
    Valle BL, Omwancha WS, Neau SH, Wigent RJ.
    Drug Dev Ind Pharm; 2016 Nov 09; 42(11):1903-16. PubMed ID: 27100683
    [Abstract] [Full Text] [Related]

  • 18. Systematic evaluations regarding interparticular mass transfer in spheronization.
    Koester M, Willemsen E, Krueger C, Thommes M.
    Int J Pharm; 2012 Jul 15; 431(1-2):84-9. PubMed ID: 22546294
    [Abstract] [Full Text] [Related]

  • 19. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A, Mens R, Adriaensens P, Foreman P, Gelan J, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2007 Apr 15; 66(1):83-94. PubMed ID: 17045467
    [Abstract] [Full Text] [Related]

  • 20. Improved bioavailability of darunavir by use of kappa-carrageenan versus microcrystalline cellulose as pelletisation aid.
    Thommes M, Baert L, van 't Klooster G, Geldof M, Schueller L, Rosier J, Kleinebudde P.
    Eur J Pharm Biopharm; 2009 Aug 15; 72(3):614-20. PubMed ID: 19303929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.